WO2025248089 - HALOQUINOLINES FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES
National phase entry is expected:
Publication Number
WO/2025/248089
Publication Date
04.12.2025
International Application No.
PCT/EP2025/064993
International Filing Date
30.05.2025
Title **
[English]
HALOQUINOLINES FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES
[French]
HALOQUINOLÉINES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES À MÉDIATION IMMUNITAIRE
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
Inventors
MATTEOLI, Gianluca
THEVISSEN, Karin
ZOUZAF, Anissa
DUARTE DA ROCHA PEREIRA, Joana
Priority Data
24179195.3
31.05.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2069 | |
| EPO | Filing, Examination, Granting | 8697 | |
| Japan | Filing, Examination, Granting | 2186 | |
| South Korea | Filing, Examination, Granting | 2135 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,827
Contact Us
Abstract[English]
The invention relates to a clioquinol for use in the prevention or treatment of psoriasis or of inflammatory bowel disease (IBD).[French]
L'invention concerne un clioquinol destiné à être utilisé dans la prévention ou le traitement du psoriasis ou de la maladie inflammatoire de l'intestin (IBD).